Next Article in Journal
Age Moderates the Link between Epilepsy and Self-Rated Health (SRH)
Next Article in Special Issue
COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: Outcomes after Two Years of the Pandemic
Previous Article in Journal
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics
Previous Article in Special Issue
Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study
 
 
Article

Article Versions Notes

J. Clin. Med. 2022, 11(20), 6174; https://doi.org/10.3390/jcm11206174
Action Date Notes Link
article pdf uploaded. 19 October 2022 15:36 CEST Version of Record https://www.mdpi.com/2077-0383/11/20/6174/pdf-vor
article supplementary file uploaded. 19 October 2022 15:36 CEST - https://www.mdpi.com/2077-0383/11/20/6174#supplementary
article xml file uploaded 24 October 2022 13:22 CEST Original file -
article xml uploaded. 24 October 2022 13:22 CEST Update https://www.mdpi.com/2077-0383/11/20/6174/xml
article pdf uploaded. 24 October 2022 13:22 CEST Updated version of record https://www.mdpi.com/2077-0383/11/20/6174/pdf
article html file updated 24 October 2022 13:24 CEST Original file -
article html file updated 25 October 2022 11:34 CEST Update -
article html file updated 28 February 2023 18:56 CET Update -
article html file updated 1 March 2023 23:00 CET Update https://www.mdpi.com/2077-0383/11/20/6174/html
Back to TopTop